Visionary Wealth Advisors Eli Lilly & CO Transaction History

Visionary Wealth Advisors

$1.82 Billion
Q2 2025

A detailed history of Visionary Wealth Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, Visionary Wealth Advisors holds 4,785 shares of LLY stock, worth $4.04 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

4,785

Previous 2,195 118.0%

Holding current value

$4.04 Million

Previous $1.81 Million 105.85%

% of portfolio

0.21%

Previous 0.12%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$713.71 - $898.95 $1.85 Million - $2.33 Million	2,590 Added 118.0%	4,785 $3.73 Million
Q1 2025 May 14, 2025	BUY	$725.72 - $929.72 $30,480 - $39,048	42 Added 1.95%	2,195 $1.81 Million
Q4 2024 Feb 13, 2025	BUY	$727.2 - $932.06 $342,511 - $439,000	471 Added 28.0%	2,153 $1.66 Million
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $330,475 - $410,888	-428 Reduced 20.28%	1,682 $1.49 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $127,577 - $159,991	176 Added 9.1%	2,110 $1.91 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $36,716 - $49,121	62 Added 3.31%	1,934 $1.5 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $25,734 - $30,337	49 Added 2.69%	1,872 $1.09 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $140,408 - $193,573	-323 Reduced 15.05%	1,823 $979,000
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $36,827 - $49,242	-105 Reduced 4.66%	2,146 $1.01 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $80,142 - $94,123	258 Added 12.95%	2,251 $773,000
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $1,929 - $2,248	-6 Reduced 0.3%	1,993 $729,000
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $65,818 - $75,007	-222 Reduced 10.0%	1,999 $647,000
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $15,608 - $18,327	-56 Reduced 2.46%	2,221 $720,000
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $41,774 - $51,915	178 Added 8.48%	2,277 $652,000
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $5,846 - $7,255	26 Added 1.25%	2,099 $580,000
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $80,440 - $98,993	-363 Reduced 14.9%	2,073 $479,000
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $49,290 - $63,756	-273 Reduced 10.08%	2,436 $559,000
Q1 2021 May 18, 2021	SELL	$164.32 - $212.72 $159,883 - $206,976	-973 Reduced 26.43%	2,709 $506,000
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $62,359 - $82,517	478 Added 14.92%	3,682 $622,000
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $45,328 - $52,430	310 Added 10.71%	3,204 $474,000
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $17,871 - $21,507	-131 Reduced 4.33%	2,894 $475,000
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $29,881 - $36,984	251 Added 9.05%	3,025 $420,000
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $296,596 - $367,360	2,774 New	2,774 $365,000

Others Institutions Holding LLY

# of Institutions

4,470

Shares Held

780M

Call Options Held

16.5M

Put Options Held

12.3M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $802B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Visionary Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Visionary Wealth Advisors with notifications on news.

Account

Visionary Wealth Advisors Eli Lilly & CO Transaction History